Plus   Neg

Tesla Sets Delivery Record, But Misses Expectations

Tesla Inc. (TSLA) achieved record vehicle deliveries for the third quarter, however, fell short of expectations set by Elon Musk. Shares were down 4% in late trading.

The luxury electric-car maker delivered 97,000 vehicles to customers in the third quarter, exceeding the 95,356 reported for the prior three months. Last month, Musk had told that the company had a chance to achieve the six-figure mark for the first time.

Tesla delivered 84,000 vehicles in the third quarter of 2018. The company said it achieved record net orders in third quarter and are entering fourth quarter with an increase in our order backlog.

"Nearly all of our Model 3 orders were received from customers who did not previously hold a reservation, solidifying the transition to generating strong organic demand. We are continuing to focus on increasing production to meet that demand," the company said in a statement.

The company said its delivery numbers should be viewed as "slightly conservative" as the company only counts a vehicle as sold after all paperwork has been finished.

TSLA closed Wednesday's trading at $243.13, down $1.56 or 0.64%, on the Nasdaq. The stock, however, dropped $10.01 or 4.12% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
Follow RTT